Worldwide cancer-drug revenue estimates and projections

Cancer-drug revenue is estimated at $232.5 billion in 2026 and projected at $311.2 billion in 2031. The outlook uses September 2026 data and covers worldwide prescription and over-the-counter sales. Source: Statista